AU Patent

AU2006214314B2 — Sphingosine 1- phos phate agonists comprising cycloalkanes and 5 -membered heterocycles substituted by amino and phenyl groups

Assigned to UVA Licensing and Ventures Group · Expires 2012-02-09 · 14y expired

What this patent protects

The present invention provides sphingosine-1-phosphate analogs that are potent, and selective agonists at one or more S1P receptors, specifically the S1P receptor type. The compounds invention include compounds having a phosphate moiety as well as compounds with hydrolysis-resist…

USPTO Abstract

The present invention provides sphingosine-1-phosphate analogs that are potent, and selective agonists at one or more S1P receptors, specifically the S1P receptor type. The compounds invention include compounds having a phosphate moiety as well as compounds with hydrolysis-resistant phosphate surrogates such as phosphonates, -substituted phosphonates, and phosphothionates.

Drugs covered by this patent

Patent Metadata

Patent number
AU2006214314B2
Jurisdiction
AU
Classification
—
Expires
2012-02-09
Drug substance claim
No
Drug product claim
No
Assignee
UVA Licensing and Ventures Group
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.